MedTrace Logo

Chemotherapy-induced Necrosis in Ewing Sarcoma

NCT03968471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 474

Last updated 2020-01-22

No results posted yet for this study

Summary

This is single institution cases series review of histological and clinical data

Conditions

  • Ewing Sarcoma of Bone

Interventions

BEHAVIORAL

Scoring tool in Chemotherapy-induced necrosis in Ewing sarcoma

The aim of the present study is to evaluate which is the best scoring tool to determine the histological response to chemotherapy in localized Ewing sarcoma of bone. The study will exam all the different systems to evaluate the histological necrosis after neo-adjuvant chemotherapy in all patients with localized Ewing sarcomas of bone surgically treated between 1982 and 2012.

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Alberto Righi, MD · Istituto Ortopedico Rizzoli IRCCS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-13
Primary Completion
2019-12-31
Completion
2020-01-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03968471 on ClinicalTrials.gov